v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
COSTS AND EXPENSES:        
Research and development $ 16,579 $ 18,133 $ 35,001 $ 33,460
General and administrative 6,757 5,429 14,771 10,838
  23,336 23,562 49,772 44,298
Operating loss (23,336) (23,562) (49,772) (44,298)
Interest and other income, net 196 9 215 92
Net loss (23,140) (23,553) (49,557) (44,206)
Preferred stock deemed dividend 4,255 4,255
Net loss available to common stockholders $ (27,395) $ (23,553) $ (53,812) $ (44,206)
Net loss per common share, basic $ (1.22) $ (2.25) $ (2.76) $ (4.49)
Net loss per common share, diluted $ (1.22) $ (2.25) $ (2.76) $ (4.49)
Weighted average common shares outstanding, basic 22,404,371 10,483,112 19,462,280 9,843,309
Weighted average common shares outstanding, diluted 22,404,371 10,483,112 19,462,280 9,843,309

Source